| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B21B2265-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B21B2261-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B21B3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 |
| filingDate |
2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021528428-A |
| titleOfInvention |
2,3-Dihydroflo [2,3-B] Pyridine compound |
| abstract |
The present invention uses compounds of formula I (where R is H or F), or pharmaceutically acceptable salts thereof, and compounds of formula I for the treatment of neurodegenerative diseases such as Alzheimer's disease. I will provide a. [Chemical 1] |
| priorityDate |
2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |